ArticleTargeted oncology2021

Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer.

Jiani Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.